Targeting acute myeloid leukemia with a proapoptotic peptide conjugated to a toll-like receptor 2-mediated cell-penetrating peptide
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting acute myeloid leukemia with a proapoptotic peptide conjugated to a toll-like receptor 2-mediated cell-penetrating peptide
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 134, Issue 3, Pages 692-702
Publisher
Wiley
Online
2013-07-14
DOI
10.1002/ijc.28382
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- STAT3-Driven Upregulation of TLR2 Promotes Gastric Tumorigenesis Independent of Tumor Inflammation
- (2012) Hazel Tye et al. CANCER CELL
- siRNA Delivery: From Lipids to Cell-penetrating Peptides and Their Mimics
- (2012) Matt Gooding et al. Chemical Biology & Drug Design
- Cell-penetrating Peptides as a Novel Transdermal Drug Delivery System
- (2012) Saman A. Nasrollahi et al. Chemical Biology & Drug Design
- Loss of immunity-supported senescence enhances susceptibility to hepatocellular carcinogenesis and progression in Toll-like receptor 2-deficient mice
- (2012) Heng Lin et al. HEPATOLOGY
- Promiscuous Binding of Invariant Chain-Derived CLIP Peptide to Distinct HLA-I Molecules Revealed in Leukemic Cells
- (2012) Marvin M. van Luijn et al. PLoS One
- Tissue expression of Toll-like receptors 2 and 4 in sporadic human colorectal cancer
- (2011) Yasuhiro Nihon-Yanagi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Cell-penetrating TAT peptide in drug delivery systems: Proteolytic stability requirements
- (2011) Erez Koren et al. DRUG DELIVERY
- Phase II trial of vorinostat and gemtuzumab ozogamicin as induction and post-remission therapy in older adults with previously untreated acute myeloid leukemia
- (2011) R. B. Walter et al. HAEMATOLOGICA
- Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patients
- (2011) E. Arvaniti et al. HAEMATOLOGICA
- Characterization of high-affinity peptides and their feasibility for use in nanotherapeutics targeting leukemia stem cells
- (2011) Hongyong Zhang et al. Nanomedicine-Nanotechnology Biology and Medicine
- Targeted Drug Delivery by Gemtuzumab Ozogamicin: Mechanism-Based Mathematical Model for Treatment Strategy Improvement and Therapy Individualization
- (2011) Eva Jager et al. PLoS One
- Chemical genomic screening reveals synergism between parthenolide and inhibitors of the PI-3 kinase and mTOR pathways
- (2010) D. C. Hassane et al. BLOOD
- Targeting neuropilin-1 in human leukemia and lymphoma
- (2010) K. Karjalainen et al. BLOOD
- Induction of Cancer Cell Death by Self-assembling Nanostructures Incorporating a Cytotoxic Peptide
- (2010) S. M. Standley et al. CANCER RESEARCH
- Mycobacterium tuberculosisLipoproteins Directly Regulate Human Memory CD4+T Cell Activation via Toll-Like Receptors 1 and 2
- (2010) Christina L. Lancioni et al. INFECTION AND IMMUNITY
- Toll-like receptor 2 mediates invasion via activating NF-κB in MDA-MB-231 breast cancer cells
- (2009) Wenjie Xie et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A phase I/II trial of TLR-7 agonist immunotherapy in chronic lymphocytic leukemia
- (2009) D E Spaner et al. LEUKEMIA
- Blocking TLR2 Activity Attenuates Pulmonary Metastases of Tumor
- (2009) Hong-Zhen Yang et al. PLoS One
- Cellular Internalization and Distribution of Arginine-Rich Peptides as a Function of Extracellular Peptide Concentration, Serum, and Plasma Membrane Associated Proteoglycans
- (2008) Michie Kosuge et al. BIOCONJUGATE CHEMISTRY
- First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1/2 trial
- (2008) A. Hagenbeek et al. BLOOD
- TLR2 – promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity
- (2008) Ulrich Zähringer et al. IMMUNOBIOLOGY
- Novel approaches for the treatment of NHL: Proteasome inhibition and immune modulation
- (2008) Owen A. O'Connor et al. LEUKEMIA & LYMPHOMA
- The Use of TLR7 and TLR8 Ligands for the Enhancement of Cancer Immunotherapy
- (2008) E. L. J. M. Smits et al. ONCOLOGIST
- Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy
- (2007) Sébastien Deshayes et al. ADVANCED DRUG DELIVERY REVIEWS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now